APA (7th ed.) Citation

Thomas, M., Gois, P. H. F., Butcher, B. E., Ta, M. H. T., & Wyk, G. W. V. (2021). Treatment persistence to tolvaptan in patients with autosomal dominant polycystic kidney disease: A secondary use of data analysis of patients in the IMADJIN® dataset. BMC.

Chicago Style (17th ed.) Citation

Thomas, Mark, Pedro Henrique Franca Gois, Belinda E. Butcher, Michelle H. T. Ta, and Greg W. Van Wyk. Treatment Persistence to Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: A Secondary Use of Data Analysis of Patients in the IMADJIN® Dataset. BMC, 2021.

MLA (8th ed.) Citation

Thomas, Mark, et al. Treatment Persistence to Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: A Secondary Use of Data Analysis of Patients in the IMADJIN® Dataset. BMC, 2021.